Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 13

1.

Calcitonin precursors are reliable markers of sepsis in a medical intensive care unit.

Müller B, Becker KL, Schächinger H, Rickenbacher PR, Huber PR, Zimmerli W, Ritz R.

Crit Care Med. 2000 Apr;28(4):977-83.

PMID:
10809269
2.

Heart transplantation in patients over 54 years of age. Mortality, morbidity and quality of life.

Rickenbacher PR, Lewis NP, Valantine HA, Luikart H, Stinson EB, Hunt SA.

Eur Heart J. 1997 May;18(5):870-8.

PMID:
9152659
3.

Analysis of deaths in patients awaiting heart transplantation: impact on patient selection criteria.

Haywood GA, Rickenbacher PR, Trindade PT, Gullestad L, Jiang JP, Schroeder JS, Vagelos R, Oyer P, Fowler MB.

Heart. 1996 May;75(5):455-62.

4.

Transplant candidates with severe left ventricular dysfunction managed with medical treatment: characteristics and survival.

Rickenbacher PR, Trindade PT, Haywood GA, Vagelos RH, Schroeder JS, Willson K, Prikazsky L, Fowler MB.

J Am Coll Cardiol. 1996 Apr;27(5):1192-7.

5.

Expression of inducible nitric oxide synthase in human heart failure.

Haywood GA, Tsao PS, von der Leyen HE, Mann MJ, Keeling PJ, Trindade PT, Lewis NP, Byrne CD, Rickenbacher PR, Bishopric NH, Cooke JP, McKenna WJ, Fowler MB.

Circulation. 1996 Mar 15;93(6):1087-94.

PMID:
8653828
6.

Induction of nitric oxide synthase in the human cardiac allograft is associated with contractile dysfunction of the left ventricle.

Lewis NP, Tsao PS, Rickenbacher PR, Xue C, Johns RA, Haywood GA, von der Leyen H, Trindade PT, Cooke JP, Hunt SA, Billingham ME, Valantine HA, Fowler MB.

Circulation. 1996 Feb 15;93(4):720-9.

PMID:
8641001
7.

Coronary artery intimal thickening in the transplanted heart. An in vivo intracoronary untrasound study of immunologic and metabolic risk factors.

Rickenbacher PR, Kemna MS, Pinto FJ, Hunt SA, Alderman EL, Schroeder JS, Stinson EB, Popp RL, Chen I, Reaven G, Valantine HA.

Transplantation. 1996 Jan 15;61(1):46-53.

PMID:
8560573
8.

Prognostic importance of intimal thickness as measured by intracoronary ultrasound after cardiac transplantation.

Rickenbacher PR, Pinto FJ, Lewis NP, Hunt SA, Alderman EL, Schroeder JS, Stinson EB, Brown BW, Valantine HA.

Circulation. 1995 Dec 15;92(12):3445-52.

PMID:
8521566
9.

Correlation of donor characteristics with transplant coronary artery disease as assessed by intracoronary ultrasound and coronary angiography.

Rickenbacher PR, Pinto FJ, Lewis NP, Hunt SA, Gamberg P, Alderman EL, Schroeder JS, Valantine HA.

Am J Cardiol. 1995 Aug 15;76(5):340-5.

PMID:
7639157
10.

Selecting candidates for cardiac transplantation. How to assess exclusion criteria and predict who will benefit.

Rickenbacher PR, Haywood G, Fowler MB.

J Crit Illn. 1995 Mar;10(3):199-206. Review.

PMID:
10150403
11.

Incidence and severity of transplant coronary artery disease early and up to 15 years after transplantation as detected by intravascular ultrasound.

Rickenbacher PR, Pinto FJ, Chenzbraun A, Botas J, Lewis NP, Alderman EL, Valantine HA, Hunt SA, Schroeder JS, Popp RL, et al.

J Am Coll Cardiol. 1995 Jan;25(1):171-7.

12.

Incidence of myocarditis in peripartum cardiomyopathy.

Rizeq MN, Rickenbacher PR, Fowler MB, Billingham ME.

Am J Cardiol. 1994 Sep 1;74(5):474-7.

PMID:
8059728
13.

Long-term outcome after heart transplantation for peripartum cardiomyopathy.

Rickenbacher PR, Rizeq MN, Hunt SA, Billingham ME, Fowler MB.

Am Heart J. 1994 May;127(5):1318-23.

PMID:
8172060

Supplemental Content

Loading ...
Support Center